The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study.

Autor: Groves HE; Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON M5G 1 × 8, Canada., Piché-Renaud PP; Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON M5G 1 × 8, Canada., Peci A; Public Health Ontario, Toronto, ON M5G 1M1, Canada., Farrar DS; Centre for Global Child Health, The Hospital for Sick Children, Toronto, ON M5G 1 × 8, Canada., Buckrell S; Public Health Agency of Canada, Ottawa, Ontario, Canada., Bancej C; Public Health Agency of Canada, Ottawa, Ontario, Canada., Sevenhuysen C; Public Health Agency of Canada, Ottawa, Ontario, Canada., Campigotto A; Division of microbiology, The Hospital for Sick Children, Toronto, ON M5G 1 × 8, Canada., Gubbay JB; Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON M5G 1 × 8, Canada.; Public Health Ontario, Toronto, ON M5G 1M1, Canada.; University of Toronto, Toronto, ON M5S 1A1, Canada., Morris SK; Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON M5G 1 × 8, Canada.; University of Toronto, Toronto, ON M5S 1A1, Canada.
Jazyk: angličtina
Zdroj: Lancet regional health. Americas [Lancet Reg Health Am] 2021 Sep; Vol. 1, pp. 100015. Date of Electronic Publication: 2021 Jul 17.
DOI: 10.1016/j.lana.2021.100015
Abstrakt: Background: The ongoing coronavirus disease 2019 (COVID-19) pandemic has resulted in implementation of public health measures worldwide to mitigate disease spread, including; travel restrictions, lockdowns, messaging on handwashing, use of face coverings and physical distancing. As the pandemic progresses, exceptional decreases in seasonal respiratory viruses are increasingly reported. We aimed to evaluate the impact of the pandemic on laboratory confirmed detection of seasonal non-SARS-CoV-2 respiratory viruses in Canada.
Methods: Epidemiologic data were obtained from the Canadian Respiratory Virus Detection Surveillance System. Weekly data from the week ending 30 th August 2014 until the week ending the 13 th March 2021 were analysed. We compared trends in laboratory detection and test volumes during the 2020/2021 season with pre-pandemic seasons from 2014 to 2019.
Findings: We observed a dramatically lower percentage of tests positive for all seasonal respiratory viruses during 2020-2021 compared to pre-pandemic seasons. For influenza A and B the percent positive decreased to 0•0015 and 0•0028 times that of pre-pandemic levels respectively and for RSV, the percent positive dropped to 0•0169 times that of pre-pandemic levels. Ongoing detection of enterovirus/rhinovirus occurred, with regional variation in the epidemic patterns and intensity.
Interpretation: We report an effective absence of the annual seasonal epidemic of most seasonal respiratory viruses in 2020/2021. This dramatic decrease is likely related to implementation of multi-layered public health measures during the pandemic. The impact of such measures may have relevance for public health practice in mitigating seasonal respiratory virus epidemics and for informing responses to future respiratory virus pandemics.
Funding: No additional funding source was required for this study.
Competing Interests: Dr. Groves reports personal fees from Honoraria received from Abbvie for education meeting presentation, outside the submitted work. Dr. Piché-Renaud reports grants from Pfizer Global Medical Grants (Competitive grant program, investigator-led), outside the submitted work. Dr. Peci has nothing to disclose. Mr. Farrar has nothing to disclose. Mr. Buckrell has nothing to disclose. Dr. Bancej has nothing to disclose. Dr. Sevenhuysen has nothing to disclose. Dr. Campigotto has nothing to disclose. Dr. Gubbay has nothing to disclose. Dr. Morris reports personal fees from GSK Canada, personal fees from Pfizer Canada, grants from Pfizer Canada, outside the submitted work.
(© 2021 The Authors. Published by Elsevier Ltd.)
Databáze: MEDLINE